Showing results (291-300 of 343) with videos related to

Sort By:
Pageof 35
Journal for Immunotherapy of Cancer|January 7, 2021
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapyAnastasia Prokopi, Christoph H Tripp, Bart Tummers, et al.
Journal for Immunotherapy of Cancer|November 8, 2023
Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancerKelly Boelaars, Laura Goossens-Kruijssen, Di Wang, et al.
Blood|August 14, 2010
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosisDirk Lievens, Alma Zernecke, Tom Seijkens, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone SarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
The Journal of Experimental Medicine|January 27, 2010
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileEsther Lutgens, Dirk Lievens, Linda Beckers, et al.
Nature Communications|February 14, 2020
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanomaElena Galvani, Piyushkumar A Mundra, Sara Valpione, et al.
Molecular Therapy. Oncology|November 4, 2024
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Immunity|December 20, 2015
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate NeuroinflammationNatalia B Pikor, Jillian L Astarita, Leslie Summers-Deluca, et al.
Pageof 35